Mice models form the backbone of applied as well as fundamental life science research and this field has made remarkable progress over recent years, particularly since rodent genome mapping in 2001. Today, mice models have become indispensible when it comes to analyzing experimental strategies in the study of cardiovascular diseases, neurological disorders, cancer, metabolic anomalies, and other areas of human diseases.
Use of Mice Model Systems in Various Specialties
The overall mice model market is rather fragmented in nature and can be segmented on the basis of type, services, and specialty.
By type, the mice model market is categorized into hybrid/congenic, carcinogen-induced and spontaneous, inbred, conditioned/ surgically-modified, transgenic, knockout, outbred, and transplantation model. Among these, inbred mice model held the largest share of the market mainly owing to advantages such as data reproducibility and cost effectiveness. Growing applications in cardiovascular, oncology, and immunology studies is estimated to make hybrid/congenic mice model the fastest developing segment of the overall market.
The main specialties that employ mice models include central nervous system, cardiovascular, metabolism and regulation, immunology, oncology, and diabetes. By revenue, the category of metabolism and regulation dominated the overall mice model market, accounting for a share of 29.60% in 2014. Rising prevalence of diabetes, especially in developed countries, is projected to boost the use of mice models in diabetes studies over the coming years, making this segment the most rapidly developing one.
Mice model services form an integral part of the overall mice model market and are forecast to develop at a growth rate of 7.30% from 2015 to 2023. Some of the key mice model services are cryopreservation and cryorecovery, genetic testing, in-vivo and in-vitro pharmacology, breeding and rederivation, quarantine, model in-licensing, genetically-engineered model services, line rescue, and surgical.
Significant Market Growth Anticipated in Developing Markets of APAC, MENA, and RoW
Geographically, the global mice model market covers six key regions: North America, Latin America, Asia Pacific, Europe, the Middle East and North Africa, and Rest of the World. North America, followed by Europe, forms the largest mice model market in terms of revenue. These markets are fueled by presence of leading biotechnology and pharmaceutical companies and strong research activities aimed at the development of biologics and drugs.
Asia Pacific is projected to develop at the highest growth rate from 2015 to 2023 thanks to favorable economic conditions in countries such as China, Japan, Australia, and India. This improvement in the economic scenario has had a positive impact on academia and research activities, thereby fueling the demand for mice models. In addition to this, the Asia Pacific market is also driven by growing presence of contract research organizations and increase in biomedical research spending.
The mice model markets in Latin America, the MENA region, and the RoW region possess strong potential for growth. This is mainly owing to growing awareness, rise in private and public investment in biomedical research, flexible regulatory requirements, and improving healthcare infrastructure.
Browse the full Global Mice Model Market report at http://www.mrrse.com/mice-model-market
The global mice model market is characterized by the presence of leading players such as Deltagen, Inc., TransGenic, Inc., SAGE Labs, Lexicon Pharmaceuticals, Crescendo Biologics Limited, Harlan Laboratories, Inc., Charles River Laboratories, The Jackson Laboratory, ImmunoGenes AG, genOway S.A., and Taconic Biosciences, Inc.